Expression of cutaneous lymphocyte antigen is associated with a poor outcome of nasal-type natural killer-cell lymphoma

British Journal of Haematology

Volumn 118, Issue 2, 2002, Pages 482-487

  Yoshino, Tadashi ^a   Nakamura, Shigeo ^b   Suzumiya, Junji ^c   Niitsu, Nozomi ^d   Ohshima, Koichi ^c   Tsuchiyama, Junjiro ^e   Shinagawa, Katsuji ^f   Tanimoto, Mitsune ^f   Sadahira, Yoshito ^g   Harada, Mine ^h   Kikuchi, Masahiro ^c   Akagi, Tadaatsu ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

^d KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^f OKAYAMA UNIVERSITY   (Japan)

^g KAWASAKI MEDICAL SCHOOL   (Japan)

^h KYUSHU UNIVERSITY   (Japan)

Author keywords

Adhesion molecule; Cutaneous lymphocyte antigen; Nasal type lymphoma; NK lymphoma; Prognostic factor

Indexed keywords

CUTANEOUS LYMPHOCYTE ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; LYMPHOCYTE ANTIGEN; METHOTREXATE; PREDNISONE; UNCLASSIFIED DRUG; VINCRISTINE;

ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOLOGY; MALE; NATURAL KILLER CELL; NOSE CANCER; PRIORITY JOURNAL; PROGNOSIS; SKIN LYMPHOMA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NOSE NEOPLASMS; PROGNOSIS; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0036041279     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03607.x     Document Type: Article

References (18)

1. The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1
2. Report of the Committee on Hodgkin's disease staging classification
3. Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm
4. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients
5. Regression models and life tables
6. An animal model for human EBV-associated hemophgocytic syndrome
7. Nasal and nasal-type natural killer/T-cell lymphoma
8. Classification of natural killer (NK) cell and NK-like T-cell malignancies
9. Nonparametric estimation from incomplete observations
10. + NK lymphomas: Clinicopathological features and prognosis
11. Treatment outcome and prognostic factors for primary nasal lymphoma
12. Evaluation of survival data and two new rank order statistics arising in its consideration
13. Cutaneous presentation of nasal/nasal type T/NK cell lymphoma: Clinicopathological findings of four cases
14. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract
15. Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese
16. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas
17. Nasal lymphomas in Japan: A high prevalence of Epstein-Barr Virus type A and deletion within the latent membrane protein gene
18. Individual comparisons by ranking methods